Fuisz Pharma has registered breath-based diagnostic systems' patent application with the US Patent and Trademark Office (USPTO).
Fuisz operates medical devices such as personal fluid analyzers, various web and software based systems and product integrated videos.
The company also handles various drug delivery systems, abuse resistance for opioids, specialized women’s health including vaginal drug delivery, tobacco harm reduction.
Fuisz Pharma managing member Joseph Matus Fuisz said the field of breath diagnostics holds potential to extend the range of convenient and portable non-invasive diagnostic techniques.
"This patent application is directed towards addressing some of the challenges that have prevented commercial adoption of breath diagnostic systems, and specifically those challenges relating to addressing contaminants that can confuse results," Fuisz added.